Thunder Biotech
PrivateLast Round
Debt
Feb 9, 2024
Total Funding Raised
$9.2M
Company Overview
Thunder Biotech is a biotechnology company that is developing a genetically engineered macrophage technology designed to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thunder Biotech Comparables
Compare Thunder Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carisma Therapeutics | 88% | |
| RocRock Biotechnology | 82% | |
| CREATE Medicines | 77% | |
Thunder Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 9, 2024 | ||||
| Convertible Debt | Oct 5, 2022 | ||||
| VC Round | Jul 31, 2020 | ||||
| Seed | Nov 6, 2017 |
Thunder Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup Ignition Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 9, 2024
$1.1M debt round completed.
- Oct 5, 2022
$6.1M raised in convertible debt financing.
Thunder Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Thunder Biotech's valuation, stock price, and market status.